Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries

Alessio Cortellini; Gino M Dettorre; Urania Dafni; Juan Aguilar-Company; Luis Castelo-Branco; Matteo Lambertini; Spyridon Gennatas; Vasileios Angelis; Ailsa Sita-Lumsden; Jacobo Rogado; Paolo Pedrazzoli; David Viñal; Aleix Prat; Maura Rossi; Rossana Berardi; Teresa Alonso-Gordoa; Salvatore Grisanti; Georgia Dimopoulou; Paola Queirolo; Sylvain Pradervand; Alexia Bertuzzi; Mark Bower; Dirk Arnold; Ramon Salazar; Marco Tucci; Kevin J Harrington; Francesca Mazzoni; Uma Mukherjee; Zoi Tsourti; Olivier Michielin; Fanny Pommeret; Joan Brunet; Bruno Vincenzi; Giuseppe Tonini; Andrea Patriarca; Federica Biello; Marco Krengli; Josep Tabernero; George Pentheroudakis; Alessandra Gennari; Solange Peters; Emanuela Romano; David J Pinato

doi:10.1136/jitc-2022-005732

Citation Tools

PDF

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Cortellini A, Dettorre GM, Dafni U, et al

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries

Journal for ImmunoTherapy of Cancer 2022;10:e005732. doi: 10.1136/jitc-2022-005732

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password